Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prime Medicine
Biotech
Prime wins gene editing patent fight with Beam
The quarrel stemmed from a 2019 agreement between the two biotechs, which both originated from research done at the Harvard lab of David Liu, Ph.D.
Darren Incorvaia
Jul 8, 2026 11:07am
Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders
Jul 18, 2025 8:30am
Gene editor shelves sole clinical asset, lays off 25% of staff
May 19, 2025 2:28pm
BMS pays Prime $110M to form T-cell therapy pact
Sep 30, 2024 7:18am
New prime editor delivery particles help restore vision in mice
Jan 9, 2024 7:00am
Prime's prime editors fix liver disease mutation in primates
Oct 30, 2023 11:47am
